Involvement of SDF-1alpha/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma - PubMed (original) (raw)
. 2008 Jan 1;122(1):91-9.
doi: 10.1002/ijc.23083.
Affiliations
- PMID: 17893878
- DOI: 10.1002/ijc.23083
Involvement of SDF-1alpha/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma
Hiroaki Kajiyama et al. Int J Cancer. 2008.
Abstract
Epithelial ovarian carcinoma (EOC) spreads by implantation of tumor cells onto the human peritoneal mesothelial cells (HPMCs) lining the peritoneal cavity. The aim of this study was to determine whether the stromal cell-derived factor-1alpha (SDF-1alpha)/CXCR4 axis is involved in the interaction of EOC cells with HPMCs in peritoneal metastasis. Clinically, we first evaluated CXCR4 expression in sections from 36 primary EOCs using immunohistochemistry. We next examined whether SDF-1alpha played roles in EOC progression, including in proliferation, cell motility, attachment to HPMCs, and the in vivo development of peritoneal metastasis through CXCR4. Of the 36 carcinomas, 16 cases (44.4%) were positive for CXCR4 immunoexpression. Positive CXCR4 expression significantly predicted poorer overall survival compared with negative expression (p = 0.0069). We found CXCR4 expression in both EOC cells and HPMCs. In contrast, the level of production of SDF-1alpha by HPMCs was higher than that by various EOC cells. Functionally, SDF-1alpha induced enhanced attachment between ES-2 cells and HPMCs or extracellular matrix components. The enhancement of adhesion potential by SDF-1alpha was inhibited by AMD3100, a CXCR4 antagonist, and by phosphatidylinositol 3 kinase and p44/42 inhibitors. Furthermore, intraperitoneal treatment with AMD3100 resulted in reduced dissemination in nude mice inoculated with ES-2 cells. The present results suggest that there may be a link between the SDF-1alpha/CXCR4 axis and enhanced intraperitoneal dissemination of EOC and that CXCR4 may be a novel target for the treatment of EOC.
Copyright 2007 Wiley-Liss, Inc.
Similar articles
- Abortifacient metapristone (RU486 derivative) interrupts CXCL12/CXCR4 axis for ovarian metastatic chemoprevention.
Zheng N, Chen J, Li T, Liu W, Liu J, Chen H, Wang J, Jia L. Zheng N, et al. Mol Carcinog. 2017 Aug;56(8):1896-1908. doi: 10.1002/mc.22645. Epub 2017 Mar 30. Mol Carcinog. 2017. PMID: 28277622 - Cancer-associated fibroblasts promote the progression of endometrial cancer via the SDF-1/CXCR4 axis.
Teng F, Tian WY, Wang YM, Zhang YF, Guo F, Zhao J, Gao C, Xue FX. Teng F, et al. J Hematol Oncol. 2016 Feb 6;9:8. doi: 10.1186/s13045-015-0231-4. J Hematol Oncol. 2016. PMID: 26851944 Free PMC article. - CD164 regulates the tumorigenesis of ovarian surface epithelial cells through the SDF-1α/CXCR4 axis.
Huang AF, Chen MW, Huang SM, Kao CL, Lai HC, Chan JY. Huang AF, et al. Mol Cancer. 2013 Oct 5;12(1):115. doi: 10.1186/1476-4598-12-115. Mol Cancer. 2013. PMID: 24094005 Free PMC article. - Tumor-associated fibrosis: a unique mechanism promoting ovarian cancer metastasis and peritoneal dissemination.
Fujimoto H, Yoshihara M, Rodgers R, Iyoshi S, Mogi K, Miyamoto E, Hayakawa S, Hayashi M, Nomura S, Kitami K, Uno K, Sugiyama M, Koya Y, Yamakita Y, Nawa A, Enomoto A, Ricciardelli C, Kajiyama H. Fujimoto H, et al. Cancer Metastasis Rev. 2024 Sep;43(3):1037-1053. doi: 10.1007/s10555-024-10169-8. Epub 2024 Mar 28. Cancer Metastasis Rev. 2024. PMID: 38546906 Free PMC article. Review. - Therapeutics target of CXCR4 and its downstream in peritoneal carcinomatosis of gastric cancer.
Koizumi K, Kato S, Sakurai H, Hashimoto I, Yasumoto K, Saiki I. Koizumi K, et al. Front Biosci (Schol Ed). 2012 Jan 1;4(1):269-76. doi: 10.2741/s267. Front Biosci (Schol Ed). 2012. PMID: 22202059 Review.
Cited by
- Identification of homogeneous and heterogeneous variables in pooled cohort studies.
Cheng X, Lu W, Liu M. Cheng X, et al. Biometrics. 2015 Jun;71(2):397-403. doi: 10.1111/biom.12285. Epub 2015 Mar 2. Biometrics. 2015. PMID: 25732747 Free PMC article. - The Exploration of Chemokines Importance in the Pathogenesis and Development of Endometrial Cancer.
Dobroch J, Bojczuk K, Kołakowski A, Baczewska M, Knapp P. Dobroch J, et al. Molecules. 2022 Mar 22;27(7):2041. doi: 10.3390/molecules27072041. Molecules. 2022. PMID: 35408440 Free PMC article. Review. - The expression of dipeptidyl peptidase IV (DPPIV/CD26) is associated with enhanced chemosensitivity to paclitaxel in epithelial ovarian carcinoma cells.
Kajiyama H, Shibata K, Ino K, Mizutani S, Nawa A, Kikkawa F. Kajiyama H, et al. Cancer Sci. 2010 Feb;101(2):347-54. doi: 10.1111/j.1349-7006.2009.01378.x. Epub 2009 Oct 3. Cancer Sci. 2010. PMID: 19917055 Free PMC article. - Identification and characterization of cancer stem cells in ovarian yolk sac tumors.
Suzuki S, Terauchi M, Umezu T, Kajiyama H, Shibata K, Nawa A, Kikkawa F. Suzuki S, et al. Cancer Sci. 2010 Oct;101(10):2179-85. doi: 10.1111/j.1349-7006.2010.01672.x. Epub 2010 Aug 27. Cancer Sci. 2010. PMID: 20804503 Free PMC article. - PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment.
Obermajer N, Muthuswamy R, Odunsi K, Edwards RP, Kalinski P. Obermajer N, et al. Cancer Res. 2011 Dec 15;71(24):7463-70. doi: 10.1158/0008-5472.CAN-11-2449. Epub 2011 Oct 24. Cancer Res. 2011. PMID: 22025564 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical